It looks like you're using an Ad Blocker.

Please white-list or disable AboveTopSecret.com in your ad-blocking tool.

Thank you.

 

Some features of ATS will be disabled while you continue to use an ad-blocker.

 

(submission) Stronger Labels For ADHD Drugs!

page: 1
5

log in

join
share:

posted on Aug, 22 2006 @ 10:04 PM
link   
Pharmaceutical are being asked by U.S. officials to add label warnings to drugs used to treat ADHD in an effort to bring awareness to the possible side-effects of using these drugs.
 



www.forbes.com
TUESDAY, Aug. 22 (HealthDay News) -- U.S. officials have asked a pharmaceutical company to add a label warning of a risk for heart problems for patients taking the prescription drug Dexedrine, a stimulant used to treat attention-deficit hyperactivity disorder (ADHD).

The warning describes some instances of sudden death in children and teens with structural cardiac abnormalities or other heart problems. It also mentions various potential psychological side effects, including hallucinations or delusional thinking. The U.S. Food and Drug Administration could not be reached for comment, and it was unclear what other ADHD drugs might be affected by this new warning. Back in May, the FDA had asked makers of similar stimulant ADHD drugs to add the warnings.

"This had already been done with other stimulants," said Dr. Melvin Oatis, an assistant professor of clinical psychiatry at New York University School of Medicine's Child Study Center. "Dexedrine is in an older class of stimulant,s and not much new had been done with that."


Please visit the link provided for the complete story.


Some of the risk of side-effects of these drugs would seem to out weight the problem. Is a person willing to risk sudden death of their child over hyperactivity? some of the other side-effects are equally alarming, to include heightened risks for psychosis, bipolar illness and aggression.

Related News Links:
seattlepi.nwsource.com
www.newstarget.com

[edit on 23/8/2006 by Mirthful Me]




new topics
 
5

log in

join